Shoichi Mori
Papers
2
Total Citations
7
H-Index
2
About
Dr. Shoichi Mori is a leading thoracic surgeon whose research focuses on optimizing postoperative outcomes in minimally invasive lung cancer surgery, with a particular emphasis on pain management. His major contributions stem from his leadership in the Japanese RATS Interest Group (J-RATSIG), where he spearheaded the landmark J-RATSIG 01 study—a prospective multi-institutional trial that rigorously compared robot-assisted thoracic surgery (RATS) with video-assisted thoracoscopic surgery (VATS). This pivotal work, cited 4 times, challenged prevailing assumptions by demonstrating that RATS was non-inferior but not superior to VATS in reducing postoperative pain. Building on these findings, Dr. Mori conducted a secondary analysis (2025, 3 citations) that isolated the clinical value of uniportal VATS, revealing that reducing the number of ports significantly alleviates pain. His research has directly informed surgical protocols, encouraging a shift toward less invasive approaches. By systematically evaluating real-world outcomes across multiple institutions, Dr. Mori has provided evidence-based guidance for thoracic surgeons worldwide, making him a key figure in advancing patient-centered care in thoracic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2